Lincoln Pharmaceuticals has clarified that the company has made timely disclosures of all the events and information which fall under the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and which otherwise would be necessary for investors to know for making sound investment decision. The Company hereby confirmed that there are no other major events which have occurred or likely to occur in near future which, can have major bearing on the operations/ performance of the Company or Company’s working or financial positions including all price sensitive information of the scrip. If any of such event will occur then the Company will immediately intimate the same to the exchanges in due compliance of relevant regulations.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1850.40 |
| Dr. Reddys Lab | 1310.50 |
| Cipla | 1365.25 |
| Zydus Lifesciences | 939.10 |
| Lupin | 2442.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: